Combined modality treatment of Hodgkin’s disease confined to lymph nodes. Results 14 years later
Although extended field radiotherapy can cure most patients with Hodgkin’s disease confined to lymph nodes, a significant number of potentially curable patients given radiotherapy alone relapse and ultimately die of their disease. Combination chemotherapy produces complete remission and prolonged disease-free survival in the majority of patients with advanced disease [1–4]. This study was initially designed following a pilot investigation which demonstrated the feasibility of a combined modality approach to the treatment of early Hodgkin’s disease, confined to lymph nodes [5, 6]. We are reporting 14 years of follow-up data from this study , begun at the Baltimore Cancer Research Center of the NCI (now the University of Maryland Cancer Center).
KeywordsToxicity Lymphoma Cobalt Leukemia Adenocarcinoma
Unable to display preview. Download preview PDF.
- 15.Schlossberger NM and Wiernik PH (1980). The pulmonary function of post-therapy Hodgkin’s disease patients. Proc Amer Assoc Cancer Res and Amer Soc Clin Oncol 21: 468.Google Scholar
- 19.O’Dwyer PJ, Wiernik PH, Stewart MB, and Slawson RG (1985). Treatment of early stage Hodgkin’s disease: A randomized trial of radiotherapy plus chemotherapy versus chemotherapy alone. In: Cavalli F, Bonadonna G, and Rozencweig M (Eds). Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances, pp 329–336. Boston: Martinus Nijhoff.Google Scholar